Millennium Management’s Neuronetics STIM Stock Holding History

Millennium Management’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-30,800	Closed	-$137K	–	7464
2021 Q4	$137K	Buy	+30,800	New	+$151K	﹤0.01%	6117

Other funds holding STIM

MAM

Madryn Asset Management New York $34.1M AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management's STIM Position: Q1 2026 in Review

Millennium Management sold out of Neuronetics (STIM) in Q1 2026, closing a stake of 10,817 shares — an estimated $14.9K sold.

Millennium Management first reported a position in STIM in Q2 2018 and held it in 23 quarters. The position peaked at $3.9M in Q1 2021. 99 funds tracked by Wall St. Rank hold STIM as of Q1 2026.

Millennium Management reported no remaining Neuronetics position as of Q1 2026 after selling out during the quarter.
Millennium Management sold 10,817 Neuronetics shares in Q1 2026, an estimated $14.9K.
Millennium Management first reported a position in Neuronetics in Q2 2018 and held it in 23 quarters.
Millennium Management's Neuronetics position peaked at $3.9M in Q1 2021.
99 funds tracked by Wall St. Rank held Neuronetics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.